Neoh, C F <br/><br/>
Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey.  [electronic resource] 

 -  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology  Mar 2018 
 - 537-544 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1435-4373 
<br/><br/><label>Standard No.: </label>10.1007/s10096-017-3147-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antifungal Agents--economics<br/>Candidemia--drug therapy<br/>Candidiasis, Invasive--drug therapy<br/>Caspofungin<br/>Cost-Benefit Analysis<br/>Databases, Factual<br/>Echinocandins--economics<br/>Humans<br/>Lipopeptides--economics<br/>Micafungin<br/>Models, Economic<br/>Treatment Outcome<br/>Turkey--epidemiology